Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (4)
  • 2025 (55)
  • 2024 (52)
  • 2023 (84)
  • 2022 (104)
  • 2021 (98)
  • 2020 (36)
  • 2019 (23)
  • 2018 (5)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4206)
  • Synthetic drugs (1140)
  • Guns/Weapons (1039)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (644)
  • Guilty Plea (558)
  • Seizures (Drugs/Property) (482)
  • Prescription Drugs (371)
  • Overdose (327)
  • Major Law Enforcement Operation (277)
  • Diversion Division (254)
  • Task Forces/Task Force Officers (237)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (188)
  • Fentanyl Awareness (166)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (68)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (39)
  • Counterfeit Pills (38)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (13)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Take Back Day (246)
  • Pharmaceuticals/Pharmacists/Physicians (228)

Drug Name

  • Oxycodone (53)
  • Opioids (47)
  • Fentanyl (29)
  • Hydromorphone (17)
  • Synthetic Opioids (13)
  • Morphine (8)
  • Benzodiazepines (7)
  • Methamphetamine (4)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Cocaine (2)
  • Barbiturates (1)
  • GHB (1)
  • Heroin (1)

Field Division

  • St. Louis (43)
  • Washington, DC (43)
  • Seattle (34)
  • Sede (34)
  • Chicago (28)
  • Miami (28)
  • New York (28)
  • Atlanta (23)
  • Omaha (23)
  • El Paso (22)
  • Louisville (21)
  • New Jersey (20)
  • Phoenix (19)
  • New Orleans (14)
  • Rocky Mountain (14)
  • San Diego (14)
  • Houston (11)
  • Dallas (10)
  • San Francisco (10)
  • Philadelphia (9)
  • New England (8)
  • Los Angeles (7)
  • Detroit (1)
Clear All Results
465 Results - Showing 391 to 400
PRESS RELEASE

Prison healthcare company agrees to $215,000 settlement relating to Controlled Substances Act claims

ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Centurion Correctional Healthcare New Mexico has agreed to a $215,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). Centurion...
PRESS RELEASE

San Antonio Physician Agrees to Pay $350,000 to Resolve Allegations that he Pre-Signed Prescriptions and Issued Prescriptions Without Appropriate Examinations

SAN ANTONIO - Doctor Hugo A. Rojas, owner of Hugo A. Rojas, M.D., P.A., and Family Clinics of San Antonio, has agreed to pay $350,000.00 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA) and the False Claims Act (FCA), announced Drug...
PRESS RELEASE

DEA Denver Announces 20th Take Back Day

With opioid overdose deaths increasing during the pandemic, the Drug Enforcement Administration announced its 20th Take Back Day scheduled for April 24. At its last Take Back Day in October, DEA collected a record-high amount of expired, unused prescription medications, with the public turning in close to 500 tons of...
PRESS RELEASE

DEA Announces 20th Take Back Day

WASHINGTON, D.C. – With opioid overdose deaths increasing during the pandemic, the Drug Enforcement Administration announced its 20th Take Back Day scheduled for April 24. At its last Take Back Day in October, DEA collected a record-high amount of expired, unused prescription medications, with the public turning in close to...
PRESS RELEASE

The DEA Announces 20TH Take Back Day

SEATTLE - With opioid overdose deaths increasing during the pandemic, the Drug Enforcement Administration announced its 20th Take Back Day scheduled for April 24, 2021. At its last Take Back Day in October, DEA collected a record-high amount of expired, unused prescription medications, with the public turning in close to...
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
PRESS RELEASE

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act

TAMPA, Fla. - Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by failing to maintain records required by the CSA. In addition to paying a civil penalty, Vistapharm has agreed to sign separately a Memorandum of Agreement...
PRESS RELEASE

DEA launches “Secure Your Meds” winter campaign

OMAHA, Nebraska – As part of its continuing efforts to reduce drug misuse and overdose, the Drug Enforcement Administration (DEA) is launching a winter campaign urging the public to “Secure Your Meds.” The current health crisis has magnified the importance of addressing the issue of prescription-drug misuse. With Americans spending...
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
PRESS RELEASE

Pharmacy Pays $250,000 to Resolve Controlled Substances Act Violations

ATLANTA – Caduceus USA Medical Pharmacy, LLC (“Caduceus”) has agreed to surrender its DEA registration and pay $250,000 to resolve allegations that it failed to keep proper records of the controlled substances that it purchased, maintained and dispensed in violation of the Controlled Substances Act (CSA). These requirements are designed...

Paginación

  • Primera página «
  • Anterior
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Current page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster